(Q33454969)

26 July 2017

title

Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome (English)

1 reference

26 July 2017

main subject

irritable bowel syndrome

1 reference

1 reference

R Marciniak

7

0 references

Elzbieta Kaczmarek

object named as

E Kaczmarek

5

0 references

Jaroslaw Walkowiak

object named as

J Walkowiak

9

0 references

author name string

T Banasiewicz

1

1 reference

26 July 2017

Ł Krokowicz

2

1 reference

26 July 2017

Z Stojcev

3

1 reference

26 July 2017

B F Kaczmarek

4

1 reference

26 July 2017

J Maik

6

1 reference

26 July 2017

P Krokowicz

8

1 reference

26 July 2017

M Drews

10

1 reference

26 July 2017

publication date

1 February 2013

1 reference

26 July 2017

1 reference

26 July 2017

volume

15

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

204-209

1 reference

The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects.

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2012.03152.X

Irritable bowel syndrome in general practice: prevalence, characteristics, and referral

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2012.03152.X

The effects of lifestyle modification on symptoms and quality of life in patients with irritable bowel syndrome: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2012.03152.X

Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2012.03152.X

Pilot study: a randomised, double blind, placebo controlled trial of pancrealipase for the treatment of postprandial irritable bowel syndrome-diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2012.03152.X

Linaclotide: a novel approach to the treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2012.03152.X

Colonic butyrate- algesic or analgesic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2012.03152.X

Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2012.03152.X

Development and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2012.03152.X

Achieving translation in models of visceral pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2012.03152.X

Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2012.03152.X

Design of treatment trials for functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2012.03152.X

Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2012.03152.X

Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2012.03152.X

The effect of inactivated Lactobacillus LB fermented culture medium on symptom severity: observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2012.03152.X

10.1111/J.1463-1318.2012.03152.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference